Applying the Stages of Change model to Type 2 diabetes care in Trinidad: A randomised trial
© Partapsingh et al; licensee BioMed Central Ltd. 2011
Received: 13 January 2011
Accepted: 11 October 2011
Published: 11 October 2011
To improve glycaemic control among Type 2 diabetics using patient-physician consultations guided by the Stages of Change (SOC) model.
Design and Methods
A randomised trial was conducted. After ensuring concealment of allocation, Type 2 diabetics were randomly assigned to receive the intervention or the control. The intervention consisted of identifying each patient's Stage of Change for managing their diabetes by diet, exercise and medications, and applying personalised, stage-specific care during the patient-physician consultations based on the SOC model. Patients in the control group received routine care. The variables of interest were effect on glycaemic control (measured by the difference in HbA1c levels) and patients' readiness to change (measured by identifying patients' SOC for managing their diabetes by diet, exercise and medications).
Participants were primarily over age 50, male and Indo-Trinidadian. Most had received only a primary school education and over 65% had a monthly income of $320 USD/month or less. Sixty-one Type 2 diabetics participated in each arm. Three patients were lost to follow-up in the intervention arm. After 48 weeks, there was an overall increase in HbA1c of 0.52% (SE 0.17) and 1.09% (SE 0.18) for both the intervention and control groups respectively. There was a relative reduction in HbA1c of 0.57% (95% CI 0.07, 1.07) with the intervention group compared to the control (p = 0.025). For exercise and diet there was an overall tendency for participants in the intervention arm to move to a more favourable SOC, but little change was noted with regards medication use.
The result suggests a tendency to a worsening of glycaemic control in this population despite adopting more favourable SOC for diet and exercise. We hypothesized that harsh social conditions prevailing at the time of the study overrode the clinical intervention.
The Stages of Change model postulates behavioural change as a process of 5 identifiable stages through which patients pass: precontemplation, contemplation, preparation, action and maintenance [1–3]. The model illustrates that for most persons a change in behaviour occurs gradually, with the patient moving from being uninterested, unaware or unwilling to make a change (precontemplation), to considering a change (contemplation), or deciding and preparing to make a change (preparation); genuine, determined action is then taken and, over time, attempts to maintain the new behaviour occur . This 'stage' concept allows for applying a temporal dimension to the Stages of Change . Within the model, relapses are almost inevitable and become part of the process of working toward life-long change .
The Stages of Change model has been evaluated in a number of contexts [1, 3, 5], and although not widely used to provide care for Type 2 diabetes, it has been used to guide interventions for dietary change  and exercise behavior , both of which are important in managing diabetes. The intervention for this study was developed incorporating the Stages of Change model into the patient-physician consultation and attempted to answer the question: Does using the Stages of Change model to provide stage-specific and personalised care for managing Type 2 diabetes by diet, exercise and medications, improve glycaemic control in the Trinidadian setting?
Trinidad and Tobago has the sixth highest prevalence of diabetes mellitus in the Caribbean , affecting between 10 - 20% of adults, 85-90% of whom can be classified as Type 2 diabetics [7, 8]. Care for these patients in the public health system in Trinidad and Tobago is provided by specialists at secondary and tertiary care centres and by primary care physicians at over 70 Primary Health Care (PHC) centres. This research was conducted at the Ste. Madeleine Health Centre (SMHC) in south Trinidad. At this clinic, care for Type 2 diabetes is offered through weekly sessions: the Chronic Disease (CD), Phlebotomy, Dietician, and Walk-in clinics. Approximately 50 patients are scheduled for each session with return visits in 16 weeks. The governing health authority requires that Walk-In clinic services be available everyday, all day. To facilitate this, the Walk-In clinic is conducted simultaneously with the CD clinic, using the same staff members. Two audits illustrate the limits of the present policy. The first, an audit of diabetic control suggested that mean HbA1c was 8.5%. Additionally an audit of patient-physician consultation time determined that 59% of consultations lasted less than 6 minutes and 38% lasted 4 minutes or less. International studies report average consultations in primary care to range from 7-10 minutes . Compromising on consultation time for apparent efficiency may act to diminish patient autonomy and encourage medical paternalism by limiting discussion of patient values, alternative treatments, or the impact of therapy on the patient's overall life . At the SMHC the current approach has resulted in an increasing numbers of Type 2 diabetics who can be described as 'frequent-visitors.'
Sample size was calculated using the formula : Sample size (per equally-sized group) = 16 ÷ (E/S)2. A desired effect (E) size of HbA1c of 1% based on the results of the UKPDS  and an audit described above which provided a mean HbA1c of 8.48% and a standard deviation (S) of the mean of 1.94% gave a sample size of 61 patients in each arm.
Inclusion and exclusion criteria
Patients were included if they were 69 years or less, were registered in the clinic's 'Chronic Disease Register' as Type 2 diabetics for the previous 12 months, not using insulin therapy at the time of recruitment and who agreed to participate after informed consent. Patients were excluded if they had plans to travel abroad for a period of more than four (4) weeks during the study, lacked decision-making capacity, or who were unable to perform activities of daily living. Additionally those who were receiving scheduled additional Type 2 diabetes care at any secondary or tertiary care center were also excluded. Once a patient was allocated to one of the treatment groups no other member of their household was eligible to participate in the study.
Primary outcome variable
The primary outcome variable measured was HbA1c level. All HbA1c samples were tested at the same laboratory in the San Fernando hospital, Southwest Regional Health Authority in Trinidad. Other variables recorded included Body Mass Index, Blood pressure, plasma urea and creatinine, total cholesterol and triglycerides and random glucometer values.
Secondary outcome variable
All assessments were based on patient self-reported data. Action stage for exercise was defined as a person being involved in physical activity of moderate intensity, 3-5 days a week for at least 30-45 minutes per day. Action stage for medication use (for a person) was defined as that person adhering to their prescribed medication regimen. Action stage for diet was assessed based on a person reporting use of a specific dietary plan for managing diabetes.
The intervention was 'stage-specific' and personalised: it delivered care to Type 2 diabetics that was specific to the patient's current SOC and specific to the patient as a whole. These formats divided each consultation into sections specific for the named SOC. Each format was translated into a form which was used at each patient-physician consultation. There were five forms in this study and each patient was exposed to the one appropriate to their present SOC with respect to diet, exercise and medication use. These forms were used as checklists for the physician to ensure all the sections of the consultation were attended to during the visit. Examples of these forms are included in the appendix (See Additional File 1). Consultation times were not measured in this study.
The control group
Patients in the control group continued with their routine care, this involved monitoring weight, blood glucose, blood pressure, discussing concerns with staff, if any recognised; and receiving a prescription for their appropriate medications.
Follow-up and adherence to protocol
The total number of patients in the control and intervention groups were divided into four (4) subgroups and seen at four (4) consecutive CD clinic sessions and four (4) clinical sessions dedicated to the stage-specific personalized care for Type 2 diabetes patients, respectively. This grouping was maintained throughout the study. This pattern was repeated for each of the three 16-week cycles. Patients from either group who did not attend the SMHC for the following compulsory scheduled visits (initial and fourth (final) plus either of 2nd or 3rd visits) were not included in the statistical hypothesis testing.
Baseline characteristics of patients in the Intervention and Control groups
Number of patients N (%)
Intervention group 61 (100)
Control group 61 (100)
Primary school (7-8 years duration)
Pension or Government assistance
Source of income
Children who are employed
Total monthly income
Duration as diabetic
> 10 years
Existing co-morbid conditions
Ischaemic Heart Disease
Outcome variables and mean values at baseline and after 48 weeks for the intervention and control groups
N = 61
At 48 weeks
N = 58
N = 61
At 48 weeks
N = 61
HbA 1 c (%)
Body Mass Index (kg/m2)
Systolic BP (mmHg)
Plasma Urea (mmol/l)
Plasma creatinine (mmol/l)
Fasting Total Cholesterol (mg/dl)
Fasting Total Triglycerides (mg/dl)
Random glucometer value (mg/dl)
Number of patients with albuminuria
Number of hypoglycemic episodes
Results from primary outcome variable and statistical test of the hypothesis
The variable " Effect on glycaemic control" was the difference in glycaemic control (HbA1c) at the start of the study from that at the end of the study for both the intervention and control groups. The significance of this "Effect on glycaemic control" was tested (α of 0.05) using the independent-samples two-sided t-test. The result of the statistical test indicated the "Effect on glycaemic control" observed for the study was significant (p = 0.025): the intervention did improve glycaemic control when compared to the control group. From Table 2, glycaemic control worsened for both groups compared to baseline. The change in glycaemic control for the intervention group was a mean increase in HbA1c of 0.52% (SE 0.17) compared to that at baseline. The change in glycaemic control for the control group was a mean increase in HbA1c of 1.09% (SE 0.18) compared to that at baseline. The "Effect on glycaemic control" or the mean difference in change in HbA1c for the intervention from the control group is -0.57% (95%CI 0.07 - 1.07). For all other variables the statistical analysis gave p-values > 0.05.
Results from secondary outcome variable - "Readiness to change"
Among these twenty-one (21) patients: two (2) shifted from precontemplation to contemplation stage; three (3) patients shifted from being in the precontemplation stage to maintaining appropriate exercise behaviour for Type 2 Diabetes; four (4) patients were able to move to setting a date to start the appropriate exercise behaviour from initially being in the contemplation stage; four (4) patients each were able to move from preparation to action stage and preparation to maintenance stage; one (1) person moved from the contemplation to the maintenance stage; and three (3) patients continued the appropriate exercise behaviour throughout the study period.
From the chart for dietary behaviour, the slope of the line graphs illustrates that over the forty-eight (48) week study period, the number of patients in the precontemplation, contemplation and preparation stages decreased while the number of patients in the action and maintenance stages increased. For exercise behaviour, the pattern is slightly different: the number of patients in the precontemplation and preparation stages decreased and the numbers in the maintenance stage increased as for dietary behaviour, however, numbers in the contemplation stage show no change and the number in the action stage actually decreased. The line graphs for medication use indicate little or no change except for a decrease in the numbers of patients in the precontemplation stage.
Data on the number of patients who moved through the stages of change was collected for both the intervention and control groups. Fewer persons experienced a shift in SOC within the control group compared to the intervention group. Within the control group, the greatest number of positive shifts also occurred with change in exercise behavior: 4 persons moved from the action to maintenance stage, 1 person shifted from precontemplation to action stage, 1 person shifted from precontemplation to maintenance stage and 1 person from preparation to action stage.
The aim of the study to improve glycaemic control by the end of the 48-week period was not realized. Interestingly however, the hypothesis test indicated there was a statistically significant difference between the change in glycaemic control measured for the intervention and control groups. The results from mean HbA1c indicated that all patients had poorer control of their diabetes at the end of the study compared to baseline. The hypothesis test indicated patients who received the intervention had a significantly smaller increase in HbA1c levels by the end of the study than those who received the control. The statistical significance of this result adds another dimension to the overall negative result as follows: although both the intervention and control groups had poorer glycaemic control reflected by higher HbA1c levels compared to baseline, the increase in HbA1c measured at the end of the 48-week period was 0.57% less with the intervention compared to the control (p = 0.025).
Implications of the study
The negative result obtained highlight two important considerations: first, there is some value to applying the SOC model to type 2 diabetes care as evidenced by the 0.57% less rise in HbA1c relative to the control group, and second, there is possibly a tendency for glycaemic control to worsen over time among patients at SMHC.
What do we know about this topic so far?
A large RCT supports the findings of this paper which suggests that patients can be moved from one stage of change to another and that this can be beneficial . The longitudinal comparisons of the stage of change shifts from Figures 2, 3 and 4 illustrated these patterns which add support to the intervention model and its theory. A crossover pattern  was observed wherein the number of patients in the precontemplation, contemplation and preparation stages (collectively) decreased while there was a simultaneous increase in the number of patients in the action and maintenance stages (collectively) at the end of the study.
In that publication application of a stage of change model based intervention resulted in a greater reduction of HbA1c than standard care, but this did not reach statistical significance . So this paper adds to the literature by illustrating that a statistically significant difference between intervention and controls can be achieved (even though there are limits to our results as we saw above).
What other factors may have caused this bilateral worsening of glycemic control in both intervention and control groups?
After dialogue with patients we postulate that severe economic stress and social hardship facing the patients who utilized the SMHC during the time of the study and contributed to the unusual results. This economic hardship occurred because of the closure of the sugar factory, Caroni (1975) Limited  which was the major employer in the Ste. Madeline area. This closure meant that study participants would not have had the financial wherewithal to fully carry out the planned behaviour change, since this would involve more expensive diets and time spent exercising. This study started in February 2006, 3 years after the closure of the sugar industry, and at a time where many of the planned social buffers had not yet been put in place.
Limitations of the Stages of Change model to Type 2 diabetes care at SMHC
The Stages of Change model was devised based on observations of people giving up smoking - an addictive behaviour requiring complete cessation . Smoking can be considered to have one common set of behaviour patterns as it is a single behaviour. Managing type 2 diabetes by diet, exercise and medication use needs to consider the interaction of three different behaviours, each having differing sets of patterns, and each impacting on glycaemic control.
It is possible that patients engaging in exercise and dietary behaviours can be viewed as proceeding through a continuous directional flow through steps beginning with initiating the behaviour, followed by continuing it, while constantly adapting it during the diabetes-disease trajectory. Each of these steps, in turn, can be considered to have their unique set of SOC, including the possibility of new stages, and have their unique aims. The intervention model did not incorporate such a complex view of these behaviours and therefore it is possible that this could have contributed to the results observed.
As we noted above there is a need for economic considerations in whether the model succeeds or not.
Limitation of the study
Complete blinding at any level (single, double, triple) was not achieved in this study since the PI provided care to all patients- both the intervention and control group. The PI was aware of the limits placed on the study by his involvement in these steps and placed due care on extraction of information from notes and in care of patients to ensure his personal biases did not interfere with the conduct of the study. Ideally additional personnel should be involved but the structure of the health services clinic did not allow for this. We acknowledge that this is a serious, but not fatal, shortcoming of the study.
Planning for the future
The overall results suggest the possibility of a tendency for glycaemic control to be naturally worsened over time at SMHC. This directs attention to other factors, additional to the nature or style of the patient-physician consultation, that are instrumental to the success of achieving improved glycaemic control among type 2 diabetes at SMHC. These factors can include external physical factors, external psychological factors and internal psychological factors .
The intervention used in this study was unable to improve overall glycaemic control for patients at SMHC despite the statistical significance of the relative reduction in HbA1c. The importance of other factors, especially the socio-economic factors influencing glycaemic control at SMHC, has been highlighted. Additionally, the possibility of an inherent tendency for glycaemic control to be worsened at SMHC, due to the influence of these factors, creates a worrying situation at the centre. The negative results obtained from this study provide a focal point to continue the search for an appropriate intervention to effectively improve HbA1c at the centre.
- Zimmerman GL, Olsen CG, Bosworth MF: A 'Stages of Change' Approach to Helping Patients Change Behavior. American Family Physician. 2000, 61: 1409-16.PubMed
- Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D, Rossi SR: Stages of Change and Decisional Balance for 12 Problem Behaviors. Health Psychology. 1994, 13 (1): 39-46.View ArticlePubMed
- Prochaska JO, Velicer WF, DiClemente CC, Fava J: Measuring process of change: Application to smoking cessation. Journal of Consulting and Clinical Psychology. 1988, 56 (4): 520-8.View ArticlePubMed
- Cancer Prevention Research Centre: Detailed Overview of the Transtheoretical Model. 2004, http://www.uri.edu/research/cprc/TTM/detailedoverview.htm
- Ni Mhurchu C, Margetts BM, Speller VM: Applying the Stages-of-Change Model to Dietary Change. Nutrition Reviews. 1997, 55 (1): 10-16.View ArticlePubMed
- World Health Organisation (WHO): WHO country and regional data. http://www.who.int/diabetes/facts/world_figures/en/index3.html
- Gulliford MC, Ariyanayagam-Baksh SM, Bickram L, Picou D, Mahabir D: Social Environment, Morbidity and Use of Health Care among People with Diabetes Mellitus in Trinidad. Internal Journal of Epidemiology. 1997, 26 (3): 620-7. 10.1093/ije/26.3.620.View Article
- American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care. 2005, 28 (Suppl 1): 4-36.View Article
- Collier J: Oxford Handbook of Clinical Specialties. 2000, London: Oxford University Press, 5
- Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: Self -management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004, 164 (15): 1641-9. 10.1001/archinte.164.15.1641.View ArticlePubMed
- Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB: Designing Clinical Research. 2001, Philadelphia (PA): Lippincott, Williams, Wilkins, 2
- Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA: Association of glycemia and macrovascular and microvascular complication of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-12. 10.1136/bmj.321.7258.405.PubMed CentralView ArticlePubMed
- Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi SR, Rossi JS, Greene G, Prochaska JO, Zinman B, Diabetes Stages of Change (DiSC) Study: Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care. 2003, 26 (3): 732-7. 10.2337/diacare.26.3.732.View ArticlePubMed
- Prochaska JO, DiClemente CC, Norcross JC: In Search of How People Change. American Psychologist. 1992, 47 (9): 1102-1114.View ArticlePubMed
- Chullén J: Sweet words and harsh facts in Trinidad's sugar industry. 2010, http://www.ilo.org/wcmsp5/groups/public/---ed_dialogue/---actrav/documents/publication/wcms_111457.pdf
- Goldberg DN, Hoffman AM, Farinha MF, Marder DC, Tinson-Mitchem L, Burton D, Smith EG: Physician Delivery of Smoking-Cessation Advice Based on the Stages-of-Change Model. Am J Prev Med. 1994, 10 (5): 267-74.PubMed
- Zgibor JC, Simmons D: Barriers to Blood Glucose Monitoring in a Multiethnic Community. Diabetes Care. 2002, 25: 1772-1777. 10.2337/diacare.25.10.1772.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.